4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-18-009205
Options or other derivatives
- President and CEO acquired 286,083 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Schultz Kare · President and CEO
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-02-09 | Grant or award : show line 1 in the form Stock Options (right to buy) | +205,482 | 205,482 | D |
| 2018-02-09 | Grant or award : show line 2 in the form Restricted Share Units | +80,601 | 80,601 | D |
Loading xslF345X03/doc4.xml…